Local-medicine-applying medicine composition including puerarin, brinzolamide and the like

A technology for topical administration and composition, applied in the field of pharmaceutical compositions such as glazolamide for topical administration, can solve the problems of rapid recovery of unfavorable conditions, prolonged treatment time, poor medication compliance, etc., and achieve inhibition or treatment or improvement. The effect of conjunctival hemorrhage symptoms, reducing adverse reactions, and reducing drug costs
CN112972683APending Publication Date: 2021-06-18ๅˆ˜ๅŠ›
13 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
ๅˆ˜ๅŠ›
Publication Date
2021-06-18

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention provides a medicine composition containing an effective dosage of puerarin and an effective dosage of dorzolamide or brinzolamide or prostaglandin, such as latanoprost, tafluprost and the like or / and an effective dosage of water-retaining agent or wetting agent or antixerophthalmic ingredients, and application in preparation of medicines, including eye-purpose medicines used for preventing or treating intraocular pressure or elevated intraocular pressure, glaucoma, fundi diseases, optic nerve protection, dry eyes or xerophthalmia or dry eye syndromes of the human being or mammals. The medicine disclosed by the invention has a better curative effect or a smaller side effect or better treatment compliance or a better treatment mode.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the technical field of medicine, in particular to provide prevention or treatment of increased intraocular pressure, glaucoma, fundus diseases, such as retinal arteriovenous occlusion, optic atrophy, dry eye disease, protection of optic nerve, treatment of inflammatory skin diseases, etc. and Effective dose of puerarin or its pharmaceutically acceptable salt or its solvate and effective dose of dorzolamide or brinzolamide or prostaglandins such as latanoprost, tafluprost etc. or its pharmaceutically acceptable Pharmaceutical compositions and uses of salts and the like. Background technique

[0002] Glaucoma (glaucoma) is a group of optic nerve diseases, including the loss of retinal ganglion cells. It is the second most blind eye disease in the world. If it is not treated in time, it will cause visual field defect or complete loss, leading to blindness. It is the most important cause of irreversible blindness. reason. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More